Structure (Spironolactone 01)
Spironolactone Tablet
Product Images NDC 71335-2301
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 71335-2301). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Spironolactone 02)
The text appears to be a description of a study comparing the effectiveness of Spronolctone and placebo. The study includes a log-rank p-value indicating statistical significance. The duration of the study spans 48 months, with evaluations at 4, 6, 12, 18, 24, 30, 36, 42, and 48 months.*
Figure 2 (Spironolactone 03)
Label (Lbl713352301)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
